Abstract
Since the introduction of blood analysis performed before major cycling events in 1997, there have been discussions concerning the quality of the results. The aim of our study therefore was to measure blood samples and compare the results obtained on the field with those obtained in the laboratory. For this it was necessary to have blood samples analysed with different instruments to determine the exactness of the results and evaluate the performances of these instruments in order to validate the haematological testing used to reveal athletes abusing recombinant erythropoietin. We report on the haematological analysis of 177 professional cyclists who took part in the Tour de France 2001. All the blood samples were withdrawn in the morning between 7 and 9 am in Dunkerque (France) and were analysed immediately with a transportable analyser. Then the samples were flown to Lausanne (Switzerland) and were reanalysed in two independent ISO 17 025 accredited laboratories with three different analysers. The results confirmed that the most effective haematological follow-up should be performed under standardized pre-analytical conditions and with identical analysers of the same manufacturer to avoid too many variations notably on the haematocrit level and the reticulocyte count. Furthermore, this study suggests that analyses performed on the site are good and could enable the federations to perform a urinary test to detect rhEPO abuse right after the blood analysis. This time saving is essential to fight efficiently recombinant erythropoietin doping, because the half life of the hormone is very short.
Key words
Cyclist - hematocrit - haemoglobin - reticulocyte - doping
References
-
1
Gore C J, Parisotto R, Ashenden M J, Stray-Gundersen J, Sharpe K, Hopkins W. et al .
Second-generation blood tests to detect erythropoietin abuse by athletes.
Haematologica.
2003;
88
333-344
-
2
Heins M, Schossow B, Greiner L, Heil W.
Influence of storage time and temperature on haematological measurands using a Sysmex NE 8000 analyser.
Medical Laboratory Science.
2000;
24
236-242
-
3
Lasne F, de Ceaurriz J.
Recombinant erythropoietin in urine.
Nature.
2000;
405
635
-
4
Leppänen E A, Grasbeck R.
Experimental basis of standardized specimen collection: effect of posture on blood picture.
Eur J Haematol.
1988;
40
222-226
-
5
Parisotto R, Gore C J, Emslie K R, Ashenden M J, Brugnara C. et al .
A novel method utilising markers of altered erythropoiesis for the detection of recombinant human erythropoietin abuse in athletes.
Haematologica.
2000;
85
564-572
-
6
Parisotto R, Wu M, Ashenden M J, Emslie K R, Gore C J, Howe C. et al .
Detection of recombinant human erythropoietin abuse in athletes utilizing markers of altered erythropoiesis.
Haematologica.
2001;
86
128-137
-
7
Riley R S, Ben Ezra J M, Goel R, Tidwell A.
Reticulocytes and reticulocyte enumeration.
J Clin Lab Anal.
2001;
15
267-294
-
8
Robinson N, Mangin P, Schattenberg L, Saugy M.
Origine du suivi hématologique: les contrôles hématocrites dans le cyclisme.
Revue Française des Laboratoires.
2003;
350
53-59
-
9
Robinson N, Saugy M, Mangin P.
Effects of exercise on the secondary blood markers commonly used to suspect erythropoietin doping.
Clin Lab.
2003;
49
57-62
-
10 Saugy M, Robinson N, Pfister Y, Mangin P. One years' experiment with the blood screening test to fight against rhEPO doping. Schänzer W, Geyer H, Gotzmann A Recent Advances in Doping Analysis. Vol. 10. Köln; Sport und Buch Strauss 2003: 159-168
-
11 UCI .Communiqué de presse de l'Union Cycliste Internationale effectué le 30 mars 2001 à Lausanne concernant l'introduction du test EPO dans les urines. 30.3.2001
-
12
Van den B J, Devreese K, Malfait R, Van d, Wauters A, Neeis H. et al .
Reference intervals for a complete blood count determined on different automated haematology analysers: Abx Pentra 120 Retic, Coulter Gen-S, Sysmex SE 9500, Abbott Cell Dyn 4000 and Bayer Advia 120.
Clin Chem Lab Med.
2002;
40
69-73
-
13
Van der M W, Dinnissen J, Keijzer M.
Evaluation of the Sysmex XT-2000 i, a new automated haematology analyser.
Sysmex J Intern.
2002;
12
71-75
N. Robinson
Laboratoire Suisse d'Analyse du Dopage, Institut Universitaire de Médecine Légale
Rue du Bugnon 21
1005 Lausanne
Switzerland
Phone: + 412131473 30
Fax: + 41 2 13 14 70 95
Email: Neil.Robinson@inst.hospvd.ch
